MIRA INFORM REPORT

IDENTIFICATION DETAILS

Name :	MAKERS PHARMA PRIVATE LIMITED
Country :	India
Financials (as on) :	31.03.2013
TAN No.: [Tax Deduction & Collection Account No.]	CHEM08313E
PAN No.: [Permanent Account No.]	AAECM38334
Legal Form :	Private Limited Liability Company
No. of Employees :	15 (Approximately)

BUSINESS DETAILS

Line of Business :	Distributor of Pharmaceutical Products
Terms :
Selling :	Cash / Advance Payment
Purchasing :	Cash / Advance Payment

GENERAL INFORMATION

Customers :	Retailers
No. of Employees :	15 (Approximately)
Bankers :	· Citibank N. A., No.163, Anna Salai, Chennai - 600002, Tamilnadu, India · Kotak Mahindra Bank Limited, 36-38A, Nariman Bhavan, 227,D, Nariman Point, Mumbai - 400021, Maharashtra, India

Banking Relations :	---
Auditors :
Name :	K Mukesh Kumar and Associates Chartered Accountants
Address :	No.105 Govindappa Naicken Street, Suite No.18, 2nd Floor, Sowcarpet, Chennai – 600001, Tamilnadu, India
Tel. No.:	91-44-25360079 / 25394475
E-Mail :	kmjainauditor@yahoo.co.in
PAN No.:	AAKPM0347C
Associates :	Medimak Pharma

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 30.09.2013

Names of Shareholders	No. of Shares
Mahendra Kumar	10000
Veena Jain	10000
Balsari Holdings Private Limited, India	5000
Surendra Plastics Private Limited, India	10000
Hotex Merchandise Private Limited, India	5000
Total	40000

As on 30.09.2013

Equity Share Break up (Percentage of Total Equity)

Category	Percentage
Bodies corporate	50.00
Directors or relatives of Directors	50.00
Total	100.00

FINANCIAL DATA

[all figures are in Rupees Millions]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS	31.03.2013	31.03.2012	31.03.2011
I. EQUITY AND LIABILITIES
(1)Shareholders' Funds
(a) Share Capital	0.400	0.400	0.400
(b) Reserves & Surplus	23.533	17.655	13.008
(c) Money received against share warrants	0.000	0.000	0.000
(2) Share Application money pending allotment	0.000	0.000	0.000
Total Shareholders’ Funds (1) + (2)	23.933	18.055	13.408
(3) Non-Current Liabilities
(a) long-term borrowings	0.000	0.000	0.000
(b) Deferred tax liabilities (Net)	0.092	0.092	0.024
(c) Other long term liabilities	0.000	0.000	0.000
(d) long-term provisions	0.000	0.000	0.000
Total Non-current Liabilities (3)	0.092	0.092	0.024
(4) Current Liabilities
(a) Short term borrowings	67.281	53.752	45.679
(b) Trade payables	10.224	16.675	22.681
(c) Other current liabilities	4.648	7.510	8.788
(d) Short-term provisions	2.696	2.191	1.853
Total Current Liabilities (4)	84.849	80.128	79.001
TOTAL	108.874	98.275	92.433
II. ASSETS
(1) Non-current assets
(a) Fixed Assets
(i) Tangible assets	1.607	1.835	2.323
(ii) Intangible Assets	0.000	0.000	0.000
(iii) Capital work-in-progress	0.000	0.000	0.000
(iv) Intangible assets under development	0.000	0.000	0.000
(b) Non-current Investments	0.000	0.000	0.000
(c) Deferred tax assets (net)	0.000	0.000	0.000
(d) Long-term Loan and Advances	0.000	0.000	0.000
(e) Other Non-current assets	0.000	0.000	0.000
Total Non-Current Assets	1.607	1.835	2.323
(2) Current assets
(a) Current investments	0.000	0.000	0.000
(b) Inventories	40.848	42.163	28.835
(c) Trade receivables	57.236	47.169	55.594
(d) Cash and cash equivalents	2.907	0.544	0.623
(e) Short-term loans and advances	6.276	6.564	5.058
(f) Other current assets	0.000	0.000	0.000
Total Current Assets	107.267	96.440	90.110
TOTAL	108.874	98.275	92.433

PROFIT & LOSS ACCOUNT

	PARTICULARS		31.03.2013	31.03.2012	31.03.2011
	SALES
		Income	403.330	351.717	344.634
		Other Income	1.406	1.404	0.857
		TOTAL (A)	404.736	353.121	345.491
Less	EXPENSES
		Purchase of Stock-In-Trade	361.751	329.201	314.984
		Changes in Inventories of Finished Goods Work-In-Progress and Stock-In-Trade	1.314	(13.328)	(6.851)
		Employee Expenses	8.154	6.905	6.503
		Others Expenses	16.837	16.376	17.696
		TOTAL (B)	388.056	339.154	332.332
Less	PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C)		16.680	13.967	13.159
Less	FINANCIAL EXPENSES (D)		7.681	6.541	6.819
	PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)		8.999	7.426	6.340
Less/ Add	DEPRECIATION/ AMORTISATION (F)		0.424	0.519	0.446
	PROFIT BEFORE TAX (E-F) (G)		8.575	6.907	5.894
Less	TAX (H)		2.697	2.259	1.870
	PROFIT AFTER TAX (G-H) (I)		5.878	4.648	4.024
	Earnings Per Share (Rs.)		14.69	11.62	10.06

LOCAL AGENCY FURTHER INFORMATION

Note:

The registered office of the company has been shifted from No.56/B1, Pantheon Road, Egmore, Chennai – 600008, Tamilnadu, India to present address

RATING & COMMENTS

MIRA’s Rating :

Ba (45)

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory
Payment Behaviour :	Usually correct
Litigation :	Clear

RBI DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

LOCATIONS

Registered Office :	No.56/A2, Pantheon Road, Egmore, Chennai – 600008, Tamilnadu, India
Tel. No.:	91-44-28582828 / 28582829
Mobile No.:	91-9840032568 (Mr. Mahendra Kumar)
Fax No.:	91-44-28582830
E-Mail :	makerspharma123@yahoo.com kmjainauditor@gmail.com
Area :	1800 Sq. ft.
Location :	Rented

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.